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Background: Patient and public involvement (PPI) is central to research and service planning. Identifying effective,
meaningful ways of involvement is challenging. The cohort study ‘Do specialist services for teenagers and young adults
with cancer add value?’ follows young people for three years, examining outcomes associated with specialist care.
Participant retention in longitudinal research can be problematic potentially jeopardising study completion. Maximising
study awareness through high impact branding and publicity may improve study retention. Study names are typically
generated by researchers rather than designed with patients.
We aimed to involve young people in developing a brand identity and name to ‘Do specialist services for teenagers and
young adults with cancer add value?’.
Methods: Nine young people aged 17–26 years diagnosed with cancer when aged 14–25 years participated in a one
day workshop with further data collection at a patient conference. Methodology was similar to conventional branding
and naming exercises and was divided into six stages. The workshop comprised five stages. Stage 1: ‘What’s in a brand’
allowed young people to enquire why brands/logos are important, Stage 2: ‘Brand Transformation’ identified what
young people needed to know and believe about the study when approached about participation, Stage 3: ‘Brand
Essence’ determined how we wanted the study to be perceived by young people, Stage 4: ‘What’s in a name’
identified potential names for the study. Stage 5: ‘Logo creation’ assembled the mood and feel of logos. Stage 6 was
logo design and an electronic survey of 249 young people attending a patient conference.
Results: BRIGHTLIGHT was the final study name and the brand essence (or study personality) was friendly, supportive
and inspiring. Four logos were designed and the final logo received 47% (n = 115) of votes.
Conclusions: Acceptance and retention to BRIGHTLIGHT is higher than anticipated (80% versus 60%), this may be
related to our integral PPI strategy. We propose this reproducible methodology as an important, enjoyable, and novel
way of involving patients in research and a welcome alternative to researcher-developed acronyms. Ideally this should
be carried out prior to engaging with healthcare professionals to prevent confusion around study identity.
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A challenge for longitudinal research is retention of study
participants. Retention rates can be maximised by increas-
ing awareness of studies through high impact branding
and publicity campaigns [1]. Typically, academic-led re-
search studies have a short title, often generated by the re-
search team during protocol development. These are
normally acronyms of the longer title perceived to be rele-
vant and ‘catchy’ by the researchers. It is unclear whether
study ‘branding’ is for professionals or patient benefit [2].
Research has shown that acronym-named studies recruit
more quickly and are cited more frequently in research
compared to studies without an acronym [3]. However,
concern has been raised about the relevance and coercive
nature of some study acronyms, for example HOPE and
CURE [4].
Commercial companies invest considerable resource
into naming and branding products. This typically in-
volves consultation with the target audience for which a
product is targeted. Involvement of target audiences or
‘consumer involvement’ is common in the commercial
world and is increasingly considered to be an integral part
of good research and service planning in healthcare [5].
Patient and public involvement [PPI] in research, refers to
the active inclusion of patients, carers, service users, and
stakeholders and may be defined as research being carried
out ‘with’ or ‘by’ members of the public rather than ‘to’,
‘about’ or ‘for’ them [http://www.invo.org.uk/find-out-
more/what-is-public-involvement-in-research-2/]. As a re-
search team we have embedded the philosophy and
practice of PPI into all of our research studies: using new
learning to refine our approach to fully engage with the
teenage and young adult [TYA] population.
‘Do specialist services for Teenagers and Young Adults
[TYA] add value?’ is a National Institute for Health Re-
search funded programme of research [NIHR grant refer-
ence number RP-PG-1209-10013; www.brightlightstudy.
com]. The core of the programme is a longitudinal cohort
study determining outcomes associated with specialist TYA
cancer services. The cohort study was preceded by a series
of feasibility projects where we worked with young people
as co-researchers [6,7]. In 2009, the feasibility work was
named ‘The Essence of TYA care’ by the research team. As
part of our retention strategy for the larger cohort study we
proposed that young people taking part would receive regu-
lar study updates through a newsletter to keep participants
up to date with study progress and this would be called
‘The Essence Echo’ in keeping with the theme of our feasi-
bility work [8]. Nearing completion of our feasibility work,
we held a one day workshop with our five young co-
researchers and participants of the feasibility study, the pur-
pose of this workshop was to disseminate the study results
back to participants. During discussion at this workshop
young people suggested both ‘The Essence of TYA care’ andthe ‘Essence Echo’ were not suitable names and would fail
to engage young people in the cohort study. We sought the
views of a larger group of our target patient population
who were attending the annual Teenage Cancer Trust
patient conference – Find Your Sense of Tumour,
2011 [http://www.teenagecancertrust.org/get-clued-up/
talk-to-other-young-people/find-your-sense-of-tumour/].
During the conference approximately 200 young people
participated in an electronic survey following a
short presentation about the proposed study (https://
jtvcancersupport.com/2011/03/fysot-11-ncri-research-for-
you/). We then asked young people what they thought of
the name ‘Essence Echo’ for a study newsletter. Seven out
of ten young people responded that the name ‘Essence
Echo’ was either ‘pretty awful’ or ‘not that great’ with only
a third citing it was a suitable title.
Recruitment and data collection from young people in
the cohort study involves multiple agencies and is con-
ducted over three years. Young people are screened,
approached and recruited by healthcare professionals in
their hospital up to four months after diagnosis. At five
months they are contacted by an independent social re-
search company (Ipsos MORI) to arrange participation in
their first interview. After the first interview contact with
young people is maintained by the main co-ordinating
centre and data collection by Ipsos MORI. Thus the im-
portance of an easily recognisable name was essential to
link all three organisations to a single study over a pro-
longed period of time.
Amongst professionals the cohort study had become
known as the ‘The 2012 TYA Cancer Cohort Study’.
Shorter titles were proposed by members of the research
team, for example, ‘Essential youth study’ or ‘colossal
youth’. We informally tested these names with young
people who did not have cancer attending a university and
they were rejected. ‘Colossal youth’ in particular made
young people think of an obesity study or stomas. This
highlighted the emotive nature of study names particularly
in a young population who are conscious of their own
identity and are brand conscious.
Commercial companies aim to transform customer ex-
perience and brand engagement by activating and em-
bedding customer voice into everything they do from
product concept, to eventual launch and throughout the
life span of the product. Using our philosophy of user in-
volvement where young people have been integral
throughout our feasibility work, we sought to engage
with young people with cancer to establish an appropri-
ate study name, logo and branding attributes prior to
study opening, with guidance from independent creative
advisors. Our aim was to involve young people in nam-
ing and branding the study in a way which was appeal-
ing to young people and which may then contribute to
successful participation and retention.
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Participants and setting
The study was undertaken during a one day workshop
with subsequent data collection at a patient conference.
Young people were recruited through Internet sites known
to be used by young people with cancer, these included
Teenage Cancer Trust Facebook page and https://jtvcan-
cersupport.com/, invitations circulated to the main cancer
treatment centres for young people in the United
Kingdom. We also sent individual invitations to young
people we had previously worked with.
Ten young people responded to the invitations. Of those,
nine young people aged 17–26 years, eight female, who
were diagnosed with cancer aged between 14–25 years,
attended the workshop (details below). Participants worked
in groups of three. Three researchers (LF, FG, RT) two in-
dependent creative advisors (JM, GP) and one young per-
son (HM) who worked with us as a co-researcher also
attended the workshop.
Ethical considerations
Ethical approval was granted by a National Health
Service Research Ethics Committee as part of our pa-
tient and public involvement strategy. Written consent
for participation was obtained after scene setting during
which young people were given more information about
what the day would involve. Young people were free to
leave at any time during the workshop. Young people
were contacted individually by a researcher [LF] after
the workshop to ensure the workshop content had not
resulted in any emotional distress.
Workshop format and procedures
Participatory methods based on branding and naming
methodology used by health care advertisers were
employed [http://www.powerdecisions.com/branding-re-
search.cfm#.Uwd2qRxZBVg]. The workshop, similar to
that used to name and brand new products consisted of
six stages designed to take the young people through the
creative journey that commercial brands are subjected to
[Figure 1]. The aim and methods of each stage are
detailed below.
STAGE 1: What’s in a brand?
Aim
To introduce the importance of branding, names, and
logos to young people.
Methods
‘Logo and brand selection’.
Prior to young people arriving, the room was decorated
with well known household logos relevant to young
people. For example, Apple, North Face, Marmite, Skoda,
Mercedes, BMW, Twitter and Facebook. Inspirationalquotes were also placed on the wall to stimulate thought
and creativity [Table 1]. A selection of branded and
non-branded supermarket drinks and crisps were laid out
[cola, lemonade, and water, flavoured and plain crisps].
Young people were asked to choose the logo from the wall
they identified most with and to help themselves to a
drink and snacks.
The creative advisors described the branding of ‘Apple’
as an example of design innovation, ease of use, simplicity
and how this was reflected in all Apple advertising and
communication. A short Apple video was shown [http://
youtu.be/cpzvwkR1RYU]. The video was followed by sim-
ple explanations of some of terms and concepts to be used
in the workshop. For example, ‘brand positioning’, is de-
fined as how a product [in our case the study] is perceived
in the minds of our customers [our patients] and what
makes that product [our study] unique and beneficial. The
brand is the impression created in the mind of the pro-
spective consumer, or in this case potential study partici-
pants. To highlight the power of branding, participants
were asked to identify whether they had selected branded
or non branded crisps and drinks.
STAGE 2: Brand transformation
Aim
To develop a brand transformation model, in order to
identify the key attributes of the study which would
make patients want to take in the study.
Methods
A ten minute presentation about the proposed study
‘Do specialist services for TYA add value?’ was given by a
researcher [LF]. Young people were informed of the feasi-
bility work and told that amongst professionals the study
had become known as the ‘The 2012 TYA Cancer Cohort
Study’. After this, there was an interactive discussion be-
tween the research team, young people and the creative
advisors about the study. Study concept, design, recruit-
ment methods, target population and outcomes were all
considered.
Using the brand transformation model we gained pa-
tient insight into what are patients feeling and what is
important to them at diagnosis, participants were asked
to list how young people would be feeling at the point of
diagnosis. We asked them to describe how they would
want young people to feel when they are approached
about the study and finally what young people needed to
know about the study in order to move them from the
feelings at diagnosis to wanting to take part in the study.
Each group fed their answers back to the main group
during an interactive discussion between participants,
researchers and the creative advisors, this allowed illu-
mination and clarification of points raised, particularly
around emotions at diagnosis.
Figure 1 Schematic diagram of the six stages used to name and brand the study.
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Aim
To determine the value of the study and how it might be
perceived by young people (brand essence). The brand es-
sence is the simplest possible statement of those charac-
teristics that makes a brand unique and presents its future
source of power, for our study we aimed for it to convey a
voice, an attitude and a message to young people, the ‘takeTable 1 Illustrates examples of inspirational quotes placed on
workshop
Quote
At this very moment, there are people only you can reach… and differences
You’re happiest while you’re making the greatest contribution
One person can make a difference and every person should try
Be the change you want to see in the world
If you want things to be different perhaps the answer is to become different
Be a rainbow in someone’s cloud
If you light a lamp for someone else it will also brighten your pathhome’ message and feeling about the study we want young
people to have when hearing about or participating in the
study [9].
Methods
Each group was given a character board of a selection of
cars, boats or shoes. Character boards are used in advertis-
ing to develop the brand personality or brand essence.walls to stimulate thought and creativity during the
Origin
only you can make. Mike Dooley
Robert F. Kennedy
John F Kennedy
Mahatma Gandhi
yourself Norman Vincent Peale
Maya Angelou
Buddha
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ter board (readers can contact the authors for the original
board used). Each group chose which item on the board
would best represent the study. The Groups fed back why
they had chosen the item, which represented the study.
Following group feedback and interactive discussion the
creative advisors synthesised the results to assimilate the
brand personality.STAGE 4: Name creation
Aim
To identify potential names for the study.Methods
The creative advisors explained the importance of names
and using drinks as examples illustrated fictional names
such as Coco-Cola and Pepsi, functional names such as
Vitamin Water or emotional names like Sunny Delight
and Tropicana designed to associate the name with
sunshine and happiness.
A researcher [LF] then showed examples of other
study names and logos from current cancer studies.
Examples included:Figure 2 Representation of footwear character board to determine br
Wellington boot (readers can contact the authors for the original board u
Phaitoon at FreeDigitalPhotos.net; 2. Image by Simon Howden at FreeDig
by africa at FreeDigitalPhotos.net ; 5. Image by John Kasawa at FreeDigitalPho
artur84 at FreeDigitalPhotos.net; 8. Image by bigjom at FreeDigitalPhotos.net;
artur84 at FreeDigitalPhotos.net; 12. Image by John Kasawa at FreeDigitalPhot
by Gualberto107 at FreeDigitalPhotos.net; 15. Image by artur84 at FreeDigitalP ‘DISCOVERY’: a study looking at better pathways to
cancer diagnosis in adult cancer patients, NIHR:
RP-PG-0608-10045; http://discovery-programme.
org/index.php. The ‘I’ in DISCOVERY is a light-
house illuminating the rest of the word, and so the
study name and logo is relevant for the study and
was used an exemplar of an excellent study name
and appropriate logo;
 EURAMOS-1: a treatment trial for osteosarcoma,
the name was comprised of putting together the
first few letters of words from the group who
designed the study- EURopean and AMerican
OSteosarcoma Study Group, http://212.219.75.232/
euramos/;
 DELAY: a qualitative study about young people’s
diagnostic experiences;
 AsyMS: an Advanced Symptom Management
System utilising mobile phone technology for
patients to report cancer chemotherapy-related
symptoms.
A recap of the results from STAGES 1–3 was given and
young people worked in their groups to generate suitable
names for the ‘2012 TYA Cancer Cohort Study’ takingand identity. If the study were footwear it would be a pink
sed). Footnote for Figure 2: Copyrights for Figures. 1. Image by
italPhotos.net; 3. Image by posterize at FreeDigitalPhotos.net; 4. Image
tos.net; 6. Image by John Kasawa at FreeDigitalPhotos.net 7. Image by
9. Image by Sharron Goodyear at FreeDigitalPhotos.net ; 11. Image by
os.net; 13. Image by Boaz Yiftach at FreeDigitalPhotos.net; 14. Image
hotos.net 16. Image by bigjom at FreeDigitalPhotos.net.
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fed back their names and why they thought each one ap-
propriate for the study, young people then worked indi-
vidually and assigned two votes to their favourite name.
STAGE 5: Logo creation
Aim
To generate guidance to direct creative designers to create
appropriate logos.
Methods
The creative designers explained the concept of mood
boards, which are typically used in the construct of logos.
A range of logos were presented and interactive discussion
about their meaning followed. Participants were given
popular magazines and newspapers to browse through for
ideas, glitter and a range of stationary. Each group con-
structed one mood board for the study names with the
highest votes (BRIGHTLIGHT, LILAC and DROP) thus
creating a visual tool to guide the logo designers for the
overall of feel of the logo.
STAGE 6: Logo design and selection
Aim
To create and select a study logo.
Methods
We involved young people in all stages of branding and
naming the study apart from stage 6 logo design which
required creative expertise in advertising and design.
Following the workshop a number of logos were de-
signed by a commercial logo design company and the
creative advisors. Logos were sent to the nine young
people who attended the workshop for feedback.
The final logo was selected by young people attending
the annual patient conference ‘Find Your Sense of
Tumour’ using previously described methodology [10].
A total of 249 young people aged 14–25 took part in the
electronic survey, respondents were shown the four
logos and asked to select which logo they thought was
the most appealing.
Results
The results of each stage of the logo development are
described below in the six stages they were performed.
Stage 1
Logo selection, young people had attributed both emo-
tional and personal identity reasons for the logos they
had selected. For example, ‘This is the logo from my car,
which my boyfriend bought me before he died’, ‘This is
my computer logo which I love. It’s what I spent my wish
on’, ‘I am addicted to Twitter, my friends are always tell-
ing me not to tweet so much’, ‘I just love marmite’.Brand selection, of the nine participants, eight had
chosen a branded drink and one had chosen supermarket
cola; she explained she had picked it up by mistake but
did not want to replace it as she had opened it before she
realised. All nine had selected branded crisps. They spoke
about their branded choices in terms of better quality,
‘know what you’re getting’ and the image associated with
supermarket brands compared to independent soft drinks
and crisps.
Stage 2
Table 2 lists the results of the brand transformation exer-
cise. Patient insight at diagnosis, how the participants
wanted patients to feel when they were approached about
the study and what they needed to know and believe to fa-
cilitate this transformation from the initial feelings at diag-
nosis to wanting taking part in the study.
Stage 3
The results of the brand essence are shown below.
Group 1: If the study was a car it would be Knightrider:
Clever, unique, talks and is interactive, futuristic,
popular, famous, nationwide, sleek design [work in
progress], eye catching, making future better, first of its
kind, everyone knows who the knight rider is, globally
recognisable.
Group 2: If the study was footwear it would be a pink
wellington boot [welly]: Practical, stable, recognisable,
foot wear is forever changing but a welly is reliable, fun,
focus, simple, straight forward, evolving but no matter
how much they change they are always originals with
the same original focus.
Group 3: If the study was a boat it would be a cross
between a life boat and an elegant yacht: Part of a
team, saves lives, goes through rough waters, feel safer.
For the yacht element it looks nice, connects with the
world, peaceful and stable.
The final ‘brand essence’ or the personality of the
study was friendly, supportive and inspiring for young
people with cancer.
Stage 4
A total of 29 names were proposed. Following individu-
ally voting five names made it to the final selection list
[Table 3]. At the end of the workshop, through further
group discussion, BRIGHTLIGHT was chosen as the
final study name (reasons for exclusion of other four
names detailed in Table 3).
Stage 5
The BRIGHTLIGHT mood board is shown in Figure 3,
this informed logo design.
Table 2 Brand transformation exercise, detailing patient insight, desired transformation and what they need to know/
believe to achieve this
[A] Patient insight at diagnosis [B] Desired transformation [C] Reasons to believe
How patients feel at diagnosis How we want patients to feel when they
hear about the study
What young people need to know in order to
get from A to B
Apprehensive ‘Want to be part of this!’ Aims and objectives of study
Apprehensive Comforted Approachable
Confused Feel like their views are important Approachable
Curious Feel wanted – take part in national study Communication – telephone, email etc.
Depressed Feeling safe [details about them in study are confidential] Getting answer
Eager Helped Groovy updates
Feelings at Diagnosis Hope Hope
Frustrated Interested How will it help?
Hope Intrigued Inclusive
Horror Making a difference Info about survival
In denial Open Inspired
Lonely Part of the future Longer term
Lost Positive Meet people like you
Not interested Secure [non-isolated] Not to be alone
Not interested [in study] Sense of helpfulness Notice boards
Outcast Supported Persuasive
Over loaded To be driven Point of contact
Over loaded To be focussed Regular newsletter
Over whelmed To get involved Simple
Pressured Want to be part of it, want to make a difference Something to look forward to
Hurt Survival
Relieved [answer] User friendly
Scared Website
Shocked Welcome packs
Unknown/uncertainty What will it achieve?
Unlucky You’re not on your own
Upset
Why
Duplicate entries are where more than one Group cited this emotion.
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Four logos were selected for the final voting
exercise. The results can be seen in Figure 4; logo
number 1 was selected having received 47% of the
votes [Figure 4].Table 3 The final list of proposed study names, the meaning
Name Definition
BRIGHTLIGHT Light at the end of the tunnel, leading the way for oth
DROP Each patient represents a drop of water; lots of drops
which in turn make waves of change.
PICS Powerful Innovate Cancer Study
LILAC Living in light accommodating cancer
PYST Powerful Youth StudyPotential impact
As with most user involvement initiatives the impact is not
easily measurable. We are unable to measure what differ-
ence changing and branding the study name from ‘The
2012 TYA Cancer Cohort Study’ to BRIGHTLIGHT hasbehind each name and the reason for exclusion
Reason for exclusion
er young people. Not excluded
make a ripple, Too abstract
Other existing studies with the same acronym
Too feminine for mixed gender study
Inappropriate colloquialism
Figure 3 BRIGHTLIGHT mood board used for the logo design.
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so far the refusal rate to BRIGHTLIGHT is less than 20%,
versus an anticipated 35% which was based on refusal/con-
sent rates in other published TYA cancer studies [11-13].
We can hypothesise that involving young people in study
design, set-up and naming has positively influenced the ac-
ceptability of the study and therefore, for those who are
approached about participation, acceptance rates areFigure 4 The four final logos with comments on each from workshop
Sense of Tumour, 2012’.higher. Retention of participants for the second interview
is approximately 80% versus an anticipated 60% and this
may also be related to our PPI strategy. Anecdotally, young
people and healthcare professionals responded favourably
to the name change. In the process of re-branding the
‘2012 TYA Cancer Cohort Study’ we discovered the brand-
ing process is ideally undertaken at the point of study con-
ception and not midpoint through gaining regulatoryparticipants and voting results from attendees at ‘Find Your
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we recognise the financial constraints of doing this. A num-
ber of professionals failed to engage with the research team
when materials started to bear the BRIGHTLIGHT logo as
they did not realise this was the same as the ‘2012 TYA
Cancer Cohort Study’, which they were already familiar
with due to extensive publicity and awareness raising by the
research team among the clinical and research community.
Discussion
This paper describes the systematic way in which a re-
search study ‘Do specialist services for TYA add value?’
was renamed, branded and assigned a suitable logo -
BRIGHTLIGHT. In line with our patient and public in-
volvement strategy, we strove to ensure that branding
was directed by young people; this was especially im-
portant as attempts by the research team to rename the
study had been largely rejected by young people. An ap-
propriate and relevant study name may be of great value
in promoting awareness of a study.
In commercial marketing the importance of the ‘brand’
is recognised; consumers develop a relationship with a
product based on trust and the confidence they have in
that particular brand [14]. The brand is the ‘conveyer of
information’ and the ‘conveyer of image’ [15] and there-
fore defining the brand is fundamental to developing
confidence and trust with a product. We sought to apply
this to an academic study. We identified early in study
development the importance of a suitable name, brand
and presence for our study. A national cohort aiming to
recruit young people with cancer shortly after diagnosis
was anticipated to be ambitious. The study needed to be
easily recognisable throughout the TYA cancer commu-
nity, to both young people and health professionals, as a
research project of value; that collaboration and partici-
pation in the study was something everyone aspired to.
An important stage in this process was adopting a study
name that would not only be instantaneously recognised
but also respected.
There is little reference to the importance of naming
and branding a study in health literature; however, in mar-
keting there is a substantial body of evidence addressing
the psychology behind branding and in developing meth-
odology to ensure branding is undertaken in a rigorous
way. Brands and branding allows the customers to differ-
entiate one product from another with the use of name,
design and advertising. This has an important effect on
consumer preference and in fact a visual symbol can have
greater value than words [16]. A successful brand starts
with an effective product or service that consumers per-
ceive as adding value. Added value equates to personal
benefit and this needs to be sustainably and effectively
communicated [17]. By working with young people
throughout the feasibility work [6,7] and now in thenaming and branding process we have ensured the study
is relevant and of value to young people. On reflection,
and our advice to other researchers would be to inform
stakeholders about the pending name change and then en-
gage in specific communication about the transition from
the existing name to the new or in our case from ‘The
2012 TYA Cancer Cohort Study’ to ‘BRIGHTLIGHT’, en-
suring that materials bore both names for a short period
of time would also have been helpful.
Involving stakeholders as co-producers in branding
products is becoming increasingly recognised [14]. In
healthcare the importance of user involvement is em-
bedded in clinical practice and good research. Our phil-
osophy when branding BRIGHTLIGHT was that it must
be directed by the consumers of our product or in this
case, our study; under the guidance of experienced
healthcare advertising executives and assisted by re-
searchers, young people successfully re-branded ‘the
2012 Cohort Study’ as ‘BRIGHTLIGHT’. The name, logo
and colour scheme selected by young people is easily
recognisable on all study literature and our website
[www.brightlightstudy.com].
Conclusions
We have described an important step towards the success
of BRIGHTLIGHT. Ensuring the name is identifiable,
understandable and reputable is the building block to opti-
mising recruitment and retention into the study. Rather
than developing meaningless acronyms, we propose this as
an important, enjoyable, reproducible and novel way of in-
volving patients in research and engaging them from an
early point in study design and set up.
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